Want to see TGTX full AI Analyst Report?
TG Therapeutics (TGTX) Ownership Overview
7.54% Insiders
18.43% Mutual Funds
11.44% Other Institutional Investors
25.18% ETFs
37.41% Public Companies and
Individual Investors
The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail, and individual investors. Approximately 55.05% of the company’s stock is owned by Institutional Investors, 7.54% is owned by Insiders, and 37.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 25, 2025 | xxxxxxxxxxxxx | $162850 | |
Sep 12, 2025 | xxxxxxxxxxxxx | $672268 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $2884350 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $23618926 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $406831 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,427,819 | Institution | 10.08% | 831,405,166 | |
| 13,101,946 | Institution | 8.56% | 706,063,870 | |
| 11,756,830 | Institution | 7.68% | 633,575,569 | |
| 9,778,086 | Insider | 6.39% | 526,941,055 | |
| 4,808,855 | Institution | 3.14% | 259,149,196 | |
| 1,968,556 | Institution | 1.29% | 106,085,483 | |
| 1,646,561 | Institution | 1.08% | 88,733,172 | |
| 1,567,016 | Institution | 1.02% | 84,446,492 | |
| 1,377,119 | Institution | 0.90% | 74,212,943 | |
| 1,303,280 | Institution | 0.85% | 70,233,759 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,756,830 | Institution | 7.68% | 633,575,569 | |
| 1,646,561 | Institution | 1.08% | 88,733,172 | |
| 1,567,016 | Institution | 1.02% | 84,446,492 | |
| 1,377,119 | Institution | 0.90% | 74,212,943 | |
| 1,303,280 | Institution | 0.85% | 70,233,759 | |
| 1,300,000 | Institution | 0.85% | 70,057,000 | |
| 1,225,347 | Institution | 0.80% | 66,033,950 | |
| 933,712 | Institution | 0.61% | 50,317,740 | |
| 879,130 | Institution | 0.57% | 47,376,316 | |
| 864,254 | Institution | 0.56% | 46,574,648 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,038,433 | Institution | 5.25% | 433,191,154 | |
| 4,391,351 | Institution | 2.87% | 228,481,993 | |
| 3,718,128 | Institution | 2.43% | 200,369,918 | |
| 3,160,081 | Institution | 2.06% | 173,614,850 | |
| 2,191,082 | Institution | 1.43% | 121,364,032 | |
| 1,833,401 | Institution | 1.20% | 95,391,854 | |
| 1,585,019 | Institution | 1.04% | 85,416,674 | |
| 1,518,454 | Institution | 0.99% | 79,005,162 | |
| 1,371,071 | Institution | 0.90% | 73,887,016 | |
| 1,246,927 | Institution | 0.81% | 67,196,896 |
FAQ
Who Owns TG Therapeutics (TGTX)?
According to the latest TipRanks data, approximately 11.44% of the company's stock is held by institutional investors, 7.54% is held by insiders, and 37.41% is held by retail investors.
What percentage of TG Therapeutics (TGTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.44% of TG Therapeutics (TGTX) stock is held by institutional investors.
What percentage of TG Therapeutics (TGTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.41% of TG Therapeutics (TGTX) stock is held by retail investors.
Who owns the most shares of TG Therapeutics (TGTX)?
iShares owns the most shares of TG Therapeutics (TGTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.